Keynote Speakers
Dr. Christian Rommel
Bayer Pharmaceuticals
Christian Rommel became EVP, Global Head of Research & Development and a member of the executive committee of Bayer Pharmaceuticals in February 2021.
He joined Bayer from Roche, where he was most recently Senior VP, Global Head of Oncology, Pharma Research and Early Development (pRED). Rommel also served at Amgen as Vice President of External Research and Development. Before that role, he was Amgen’s Vice President, Research Oncology.
Previously, Christian Rommel served as Chief Scientific Officer of Intellikine, a private biotech company based in San Diego, from its inception to acquisition by Takeda. Earlier in his career, Rommel was Head of Target Research at Merck-Serono in Geneva, Switzerland. He also worked as a scientist in the team of George Yancopoulos at Regeneron Pharmaceuticals, New York.
Christian Rommel received his PhD in molecular oncology from the Max Planck Institute in Berlin, Germany and the Institute of Medical Virology at the University of Zurich, Switzerland. He is also a lecturer of biotechnology at the ETH Zurich, Switzerland. He has authored more than 70 publications, including papers in Science and Nature, and is an inventor or co-inventor of 18 patents.
Outside of work, Christian Rommel very much enjoys spending time with his family, good food paired with a good glass of wine as well as art and skiing.
Moritz Hartmann
Roche
Moritz Hartmann is Head of Roche Information Solution (RIS), which focuses on delivering data-driven solutions that empower healthcare professionals and patients to make insights-based decisions. Connecting the lab, care and home settings, these innovative digital solutions help unlock digital ecosystems across the care continuum for financial, operational, and clinical insights that drive personalized healthcare for patients around the globe.
Moritz started his career in the tourism industry developing online travel booking engines. He joined Roche in 2005 and since, has successfully led large and diverse organisations and teams across different regions and divisions while driving innovative digitisation projects and partnerships. Moritz was appointed Head of the newly created Roche Information Solutions (RIS) in May 2021.
A German native, Moritz holds degrees in Controlling and Finance as well as Marketing and International Management and an MBA from the Northwestern University - Kellogg School of Management.
Prof. Dr. Carolin Lerchenmüller
University Hospital Zurich
Carolin Lerchenmüller studied medicine at the University of Heidelberg, where she also completed her training as a cardiologist at the university hospital. After a research stay at Massachusetts General Hospital/Harvard Medical School, she took over the leadership of the Cardiac Remodeling and Regeneration Laboratory at the University Hospital Heidelberg. In 2021, she founded and has since led the "Gender Medicine Network Heidelberg”.
Prof. Lerchenmüller focuses on the protective effects of exercise on the heart, as well as the role of equity and diversity in medicine and science. She has published research on topics such as the "Gender Publication Gap" and gender-specific differences in the perception of science.
In 2024, Carolin Lerchenmüller accepted a position at the University of Zurich, where she took over the newly established Chair of Gender Medicine and will continue her clinical work in the Cardiology Department of the University Hospital Zurich.
